Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Limited has announced the closure of its trading window from Wednesday, 1st October 2025, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended 30th September 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, and the company's internal code of conduct. The board meeting date to approve these results will be communicated separately. The intimation was signed by Amol Gupta, the Chief Financial Officer, on 26th September 2025.
No direct impact on shareholders. This is a standard regulatory disclosure — insiders, directors, and employees are barred from trading the stock during this blackout period to prevent insider trading ahead of the upcoming results announcement.